Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1996
11/06/1996CN1135161A Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds
11/06/1996CN1134941A New pseudopeptides having trifluoromethyl substtuted 2-azazbicyclooctane
11/06/1996CN1134939A Method for prepn. of 3-formyl-cephem derivatives
11/06/1996CN1134938A Novel alkylated (hetero) cyclic compounds, process for their prepn. and pharmaceutical compositions contg. same
11/06/1996CN1134932A Substituted benzene sulfonyl urea and benzene sulfonyl thiourea and mfg. method and use as raw material for medicine
11/06/1996CN1134833A Composite pharmaceutics for curing dysentery
11/06/1996CN1134828A Medicine for treating hircismus
11/06/1996CN1134801A Medicinal towel and shoe pad for treating beriberi
11/06/1996CN1033227C Method for prepn. of pyrimidine nucleoside derivatives having anti-tumor activity
11/06/1996CN1033214C Capsul for curing gastric ulcer
11/06/1996CN1033209C Using sinapine as raw material for prepn. solution for preventing radiation injury
11/06/1996CN1033208C Using L-Lysine chlorhydric salt as raw material for prepn. of hemostatic
11/06/1996CN1033207C L-Lysine chlorhydric salt for treating injured skull
11/06/1996CA2175747A1 Benzopyrane derivatives used for preparing pharmaceutical compositions used in the treatment of pathology related to na+ independent cl-/hco3- exchanger
11/06/1996CA2174583A1 Sulfuric acid esters of sugar alcohols
11/06/1996CA2174582A1 Sulphuric acid esters of amino-sugars
11/05/1996US5571942 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
11/05/1996US5571937 Complementary DNA and toxins
11/05/1996US5571925 Angiotensin II antagonists
11/05/1996US5571923 3-/1-dodecyl/-5-isoxazolemethanol intermediate
11/05/1996US5571921 Substituted (2-oxo-1-benzimidazolinyl)-peperidines, process for their preparation, and use as anti-retroviral agents
11/05/1996US5571918 Reacting 3-hydroxy-3-mercaptomethylquinuclidine and a carbonyl compound in the presence of a catalyst
11/05/1996US5571917 Taxoid intermediates
11/05/1996US5571914 Antitumor agents
11/05/1996US5571902 Synthesis of oligonucleotides
11/05/1996US5571900 Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof
11/05/1996US5571846 Method of inhibiting fibrosis
11/05/1996US5571845 Nitroaniline derivatives and their use as anti-tumour agents
11/05/1996US5571844 Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants
11/05/1996US5571843 Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof
11/05/1996US5571842 Perfluoroalkyl-substituted, benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
11/05/1996US5571841 Treating skin with mandelic acid for wrinkle reduction
11/05/1996US5571840 Method for treating central nervous system ischemia
11/05/1996US5571839 D-aspartic acid β-hydroxamate for the treatment of viral infections and tumors
11/05/1996US5571837 Method of treating wrinkles using saccharic acid or saccharolactone
11/05/1996US5571836 Neuraminic acid derivatives
11/05/1996US5571835 Inhibitors of farnesyl-protein transferase
11/05/1996US5571834 Pharmaceutical composition useful for the treatment of cardiovascular diseases
11/05/1996US5571833 Tryptamine analogues, their synthesis and their use as 5-HT1 -like or 5-HT2 receptor agonists
11/05/1996US5571828 N-[(3-heteroaryl-1-pyrrolidinyl)alkyl]-2,3-napthalimides and related compounds and their therapeutic utility
11/05/1996US5571827 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
11/05/1996US5571826 Heterocyclic compounds and their preparation and use
11/05/1996US5571825 Method of selectively inhibiting prostaglandin G/H synthase-2
11/05/1996US5571823 Pharmacological treatment of ocular development
11/05/1996US5571822 Antitumor compounds
11/05/1996US5571818 Pyrrolyl-4h-pyranoisoquinolines
11/05/1996US5571817 Which are testosterone-reductase inhibitors;topical application
11/05/1996US5571816 Pyrimidines
11/05/1996US5571814 N-[(4-heteroaryl-1-pyrrolidinyl)alkyl]phthalimides and related compounds and their therapeutic utility
11/05/1996US5571813 Treatment of hypertension, congestive heart failure, renal failure
11/05/1996US5571812 7-amino-1-cyclopropyl-6,8-dihalogeno-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid antibacterial agents
11/05/1996US5571811 Treating helicobacter infection
11/05/1996US5571808 Substituted 2-aryl-3-aroylbenzo(b)thiophenes
11/05/1996US5571807 Calcium antagonists, treatment of angina and hypertension
11/05/1996US5571806 Dibenz[b,f][1,4]oxazepin(and thiazepin)-11(10H)-ones and-thiones and their use in the prevention or treatment of HIV infection
11/05/1996US5571805 Antibiotic compounds
11/05/1996US5571804 Cephalosporin antibiotics
11/05/1996US5571803 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
11/05/1996US5571802 Method of treating post menopausal osteoporosis with hexafluro-vitamin D
11/05/1996US5571801 Plasma expander and blood substitute
11/05/1996US5571800 Method for inhibiting allograft rejection by the administration of 6-azauridine or its triacetate derivative
11/05/1996US5571798 Synergistic antiviral nucleoside combinations
11/05/1996US5571795 Glycosylated steroids coupled to a drug, transportation across biological membranes
11/05/1996US5571793 Combatting endoparasites in humans or animals by administering peptides
11/05/1996US5571792 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
11/05/1996US5571783 Composition and method for treating patients with hepatic disease
11/05/1996US5571689 Method of N-acylating peptide and proteins with diheteroatom substituted analogs of myristic acid
11/05/1996US5571671 Detection of mosaic population of cells with two or three copies of chromosome 21
11/05/1996US5571666 Thiazine dyes used to inactivate HIV in biological fluids
11/05/1996US5571534 Drug formulations for parenteral use
11/05/1996US5571533 Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
11/05/1996US5571530 Respiratory system disorders by administering beta receptors for treatment of bronchitis
11/05/1996US5571528 Pilocarpine-containing chewing gum that stimulates salivation
11/05/1996US5571524 Diadenosine tetraphosphate
11/05/1996US5571523 Antioxidant-induced apoptosis in vascular smooth muscle cells
11/05/1996US5571518 Proliferation of skin
11/05/1996US5571506 Aromatic oligomeric compounds useful as mimics of bioactive macromolecules
11/05/1996US5571505 Anti-HIV oligomers
11/05/1996US5571501 Denyifrice
11/05/1996US5571186 Porous hydroxyapatite or tricalcium phosphate, 7-isopropoxyisoflavone
11/05/1996US5570683 Methods and devices for treating pulmonary vasoconstriction and asthma
11/05/1996CA2098102C Alteration of rate and character of hair growth
11/03/1996CA2175293A1 Pharmaceutical preparations having controlled release of active compound and processes for their preparation
10/1996
10/31/1996WO1996034109A1 Single-vial formulations of dna/lipid complexes
10/31/1996WO1996034106A1 Decorin binding protein compositions and methods of use
10/31/1996WO1996034099A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
10/31/1996WO1996034095A1 Human tumor necrosis factor receptors
10/31/1996WO1996034006A1 Antigenic carbohydrate derivatives and process for producing the same
10/31/1996WO1996034005A1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof
10/31/1996WO1996033999A1 NOVEL SUBSTITUTED TETRAHYDROPYRANO[3,2-d]OXAZOLONES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
10/31/1996WO1996033985A1 Piperidine derivatives as diuretic
10/31/1996WO1996033984A1 N-sulfoxy anhydrides, a process for the preparation thereof and its use for the preparation of bioactive substances having ace inhibitory action
10/31/1996WO1996033981A1 Quinazoline derivative
10/31/1996WO1996033980A1 Quinazoline derivatives
10/31/1996WO1996033979A1 Quinazoline derivatives
10/31/1996WO1996033978A1 Quinazoline derivative
10/31/1996WO1996033977A1 Quinazoline derivatives
10/31/1996WO1996033970A1 Substituted phenyl amidines, medicaments containing these compounds and process for producing them
10/31/1996WO1996033968A1 Highly water-soluble metalloproteinase inhibitor
10/31/1996WO1996033745A1 Formulations for lipophilic compounds